Aytu BioPharma Inc.
Organization details
- Legal name
- Aytu BioPharma Inc.
- Former names
- Aytu Bioscience, Inc Rosewind CORP
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Denver
- Headquarters state / province
- Colorado
- Headquarters country
- United States
- Fiscal year end
- June
- Ticker symbol
- AYTU
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001385818
- EIN
- 47-0883144
Board of directors
-
Abhinav Jain · DirectorSince 2023
-
Carl Dockery · DirectorSince 2023
-
John Donofrio Jr. · DirectorSince 2023
-
Joshua R. Disbrow · Director · Chief Executive OfficerSince 2023
-
Vivian H. Liu · DirectorSince 2023
Chief executives
Director election results
Annual meeting of December 10, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.1%
-
90.6%
-
92.3%
-
97.5%
Board connections
1 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
Talphera Inc. Same sectorvia Abhinav Jain
-
Xtant Medical Holdings Inc. Same sectorvia Abhinav Jain
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 28, 2026 | John Donofrio Jr. Director | Grant or award | +10,000 | — | — |
| Jul 28, 2026 | Carl Dockery Director | Grant or award | +10,000 | — | — |
| Jul 28, 2026 | Abhinav Jain Director | Grant or award | +10,000 | — | — |
| Jul 28, 2026 | Vivian H. Liu Director | Grant or award | +10,000 | — | — |
| Jul 28, 2026 | Selhorn Ryan J Officer (Chief Financial Officer) | Grant or award | +25,000 | — | — |
| Jul 28, 2026 | Disbrow Jarrett Officer (Chief Business Officer) | Grant or award | +15,000 | — | — |
| Jul 28, 2026 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Grant or award | +20,000 | — | — |
| Jul 28, 2026 | Joshua R. Disbrow Director, Officer (Chief Executive Officer) | Grant or award | +30,000 | — | — |
| Oct 3, 2025 | PYSZCZYMUKA GREG Officer (Chief Commercial Officer) | Grant or award | +12,500 | — | — |
| Oct 3, 2025 | Disbrow Jarrett Officer (Chief Business Officer) | Grant or award | +19,606 | — | — |
| Oct 3, 2025 | Selhorn Ryan J Officer (Chief Financial Officer) | Grant or award | +16,243 | — | — |
| Oct 3, 2025 | Joshua R. Disbrow Director, Officer (Chief Executive Officer) | Grant or award | +31,446 | — | — |
| Oct 3, 2025 | Vivian H. Liu Director | Grant or award | +10,000 | — | — |
| Oct 3, 2025 | Abhinav Jain Director | Grant or award | +10,000 | — | — |
| Oct 3, 2025 | Carl Dockery Director | Grant or award | +10,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Aytu BioPharma Inc.
Who is the CEO of Aytu BioPharma Inc.?
Joshua R. Disbrow is Aytu BioPharma Inc.'s Chief Executive Officer.
How many directors are on Aytu BioPharma Inc.'s board?
Aytu BioPharma Inc.'s board has 5 directors: Abhinav Jain, Carl Dockery, John Donofrio Jr., Joshua R. Disbrow and Vivian H. Liu.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="aytu-biopharma-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.